650 related articles for article (PubMed ID: 19650904)
1. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
[TBL] [Abstract][Full Text] [Related]
2. Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.
Tenbusch M; Nchinda G; Storcksdieck genannt Bonsmann M; Temchura V; Überla K
Int Immunol; 2013 Apr; 25(4):247-58. PubMed ID: 23184617
[TBL] [Abstract][Full Text] [Related]
3. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.
Tenbusch M; Kuate S; Tippler B; Gerlach N; Schimmer S; Dittmer U; Uberla K
BMC Immunol; 2008 Apr; 9():13. PubMed ID: 18405363
[TBL] [Abstract][Full Text] [Related]
5. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
Cruz LJ; Rosalia RA; Kleinovink JW; Rueda F; Löwik CW; Ossendorp F
J Control Release; 2014 Oct; 192():209-18. PubMed ID: 25068703
[TBL] [Abstract][Full Text] [Related]
6. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
Volckmar J; Knop L; Stegemann-Koniszewski S; Schulze K; Ebensen T; Guzmán CA; Bruder D
Vaccine; 2019 Aug; 37(35):4963-4974. PubMed ID: 31320219
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?
Niezold T; Storcksdieck Genannt Bonsmann M; Maaske A; Temchura V; Heinecke V; Hannaman D; Buer J; Ehrhardt C; Hansen W; Überla K; Tenbusch M
Immunology; 2015 Aug; 145(4):519-33. PubMed ID: 25819746
[TBL] [Abstract][Full Text] [Related]
8. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.
Trumpfheller C; Finke JS; López CB; Moran TM; Moltedo B; Soares H; Huang Y; Schlesinger SJ; Park CG; Nussenzweig MC; Granelli-Piperno A; Steinman RM
J Exp Med; 2006 Mar; 203(3):607-17. PubMed ID: 16505141
[TBL] [Abstract][Full Text] [Related]
9. CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.
Njongmeta LM; Bray J; Davies CJ; Davis WC; Howard CJ; Hope JC; Palmer GH; Brown WC; Mwangi W
Vaccine; 2012 Feb; 30(9):1624-35. PubMed ID: 22240344
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity.
Trumpfheller C; Longhi MP; Caskey M; Idoyaga J; Bozzacco L; Keler T; Schlesinger SJ; Steinman RM
J Intern Med; 2012 Feb; 271(2):183-92. PubMed ID: 22126373
[TBL] [Abstract][Full Text] [Related]
11. Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.
Kanagavelu SK; Snarsky V; Termini JM; Gupta S; Barzee S; Wright JA; Khan WN; Kornbluth RS; Stone GW
Vaccine; 2012 Jan; 30(4):691-702. PubMed ID: 22146759
[TBL] [Abstract][Full Text] [Related]
12. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
[TBL] [Abstract][Full Text] [Related]
13. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.
Bonifaz LC; Bonnyay DP; Charalambous A; Darguste DI; Fujii S; Soares H; Brimnes MK; Moltedo B; Moran TM; Steinman RM
J Exp Med; 2004 Mar; 199(6):815-24. PubMed ID: 15024047
[TBL] [Abstract][Full Text] [Related]
14. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
[TBL] [Abstract][Full Text] [Related]
15. Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.
Volckmar J; Knop L; Hirsch T; Frentzel S; Erck C; van Ham M; Stegemann-Koniszewski S; Bruder D
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616089
[TBL] [Abstract][Full Text] [Related]
16. Antigen Delivery to DEC205
Silva MO; Almeida BS; Sales NS; Diniz MO; Aps LRMM; Rodrigues KB; Silva JR; Moreno ACR; Porchia BFMM; Sulczewski FB; Boscardin SB; Ferreira LCS
Int J Biol Sci; 2021; 17(11):2944-2956. PubMed ID: 34345218
[TBL] [Abstract][Full Text] [Related]
17. HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC.
Bozzacco L; Trumpfheller C; Huang Y; Longhi MP; Shimeliovich I; Schauer JD; Park CG; Steinman RM
Eur J Immunol; 2010 Jan; 40(1):36-46. PubMed ID: 19830741
[TBL] [Abstract][Full Text] [Related]
18. A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.
Ruane D; Do Y; Brane L; Garg A; Bozzacco L; Kraus T; Caskey M; Salazar A; Trumpheller C; Mehandru S
Mucosal Immunol; 2016 Sep; 9(5):1340-52. PubMed ID: 26732678
[TBL] [Abstract][Full Text] [Related]
19. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes.
Bozzacco L; Trumpfheller C; Siegal FP; Mehandru S; Markowitz M; Carrington M; Nussenzweig MC; Piperno AG; Steinman RM
Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1289-94. PubMed ID: 17229838
[TBL] [Abstract][Full Text] [Related]
20. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
